SEMINARA, STEFANO,TAJCHERT, AGNIESZKA,SCHWARZ, FRANZ
申请号：
CA3033319
公开号：
CA3033319A1
申请日:
2017.08.09
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
It is provided a solid pharmaceutical composition comprising sofosbuvir, one or more pharmaceutically acceptable excipients and optionally at least one pharmaceutically acceptable matrix compound, wherein at least 99 weight-% of the sofosbuvir comprised in the solid pharmaceutically composition are present in amorphous form. Sofosbuvir amorphous form is stable in the solid pharmaceutical composition.
